Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy And Safety Of Terlipressin Vs Octreotide As Adjuvant Therapy In Bleeding Esophageal Varices

NCT00534677 is registered in ClinicalTrials.gov with Aga Khan University as lead sponsor.

NCT NCT00534677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00534677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy And Safety Of Terlipressin Vs Octreotide As Adjuvant Therapy In Bleeding Esophageal Varices
Lead sponsor
Aga Khan University
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2004
Completion date
July 31, 2005
Enrollment
320 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hematemesis, melena, portal hypertension